<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03287726</url>
  </required_header>
  <id_info>
    <org_study_id>2016/1297-10</org_study_id>
    <nct_id>NCT03287726</nct_id>
  </id_info>
  <brief_title>What is the Impact of Probiotics on Weight Loss Maintenance in Individuals With Obesity?</brief_title>
  <official_title>Evaluation of the Potential Impact of Probiotics on Weight Loss Maintenance in Individuals With Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian University of Life Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Norwegian University of Science and Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Weight loss maintenance is the biggest challenge in obesity management, with the majority of
      weight-reduced individuals experiencing weight regain. The intake of probiotics has been
      shown to help in weight loss, but its potential in maximizing weight loss maintenance remains
      unknown. Therefore, the main aim of this study is to investigate the impact of probiotic
      consumption on weight loss maintenance. Secondary aims are to investigate if the intake of
      probiotics influences gut microbiota, cardio-metabolic profile, appetite and inflammatory
      markers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2017</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body composition</measure>
    <time_frame>9 months</time_frame>
    <description>air displacement plethysmography (BodPod, COSMED, Italy)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>appetite suppression</measure>
    <time_frame>9 months</time_frame>
    <description>Online Visual Analogue Scale (VAS) for the measurement of subjective feelings of appetite (hunger, fullness, desire to eat, prospective consumption)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition</measure>
    <time_frame>9 months</time_frame>
    <description>Bioelectrical impedance analysis (BIA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resting metabolic rate</measure>
    <time_frame>9 months</time_frame>
    <description>indirect calorimetry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">115</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>probiotics</intervention_name>
    <description>NYCOPRO, a multistrain probiotic (7 strains of Lactobacilli and Bifidobacteria) sold in the Norwegian pharmacies. 2x/day (one with lunch and one with dinner). 2 text messages daily as a reminder. Follow up meeting at ObeCe (St. Olavs hospital) every month with a research nurse, for weighing, blood pressure measurement and collection of probiotics dose for the following month.</description>
    <arm_group_label>probiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Placebo 2x/day (one with lunch and one with dinner). 2 text messages daily as a reminder. Follow up meeting at ObeCe (St. Olavs hospital) every month with a research nurse, for weighing, blood pressure measurement and collection of probiotics dose for the following month.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  class I or II obesity (30 kg/m2 &lt; BMI &gt; 40 kg/m2)

          -  weight stable (&lt;2 kg variation in weight within the last 3 months)

          -  not currently dieting to lose weight

          -  dietary intervention of 1000 kcal energy restriction for 8 weeks using a powder based
             low energy diet product, followed by 4 week weight stabilization phase
             (re-introduction of food)

          -  women who are either post-menopausal, taking oral contraceptives or with a normal
             cycle (28 ± 2 days)

        Exclusion Criteria:

          -  consumption of probiotics 6 months before taking part in the study

          -  pregnant

          -  breast-feeding

          -  drug or alcohol abuse within the last two years

          -  currently taking medication known to affect appetite or induce weight loss

          -  enrolled in another obesity treatment program

          -  history of psychological disorders

          -  having had bariatric surgery

          -  metabolic diseases (such as hypo/hyperthyroidism and diabetes type 1 or 2)

          -  eating disorders

          -  lactose intolerance

          -  gastrointestinal (particularly cholelithiasis), kidney, liver, lung, cardiovascular
             disease

          -  malignancies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torstein Baade Rø, phd prof</last_name>
    <role>Study Chair</role>
    <affiliation>Norwegian University of Science and Technology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Ann Roekenes</last_name>
    <phone>0047 72837002</phone>
    <email>jessica.roekenes@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Catia Martins, phd</last_name>
    <email>catia.martins@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Roekenes</last_name>
      <email>jessica.roekenes@ntnu.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2017</study_first_submitted>
  <study_first_submitted_qc>September 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2017</study_first_posted>
  <last_update_submitted>December 8, 2017</last_update_submitted>
  <last_update_submitted_qc>December 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Probiotics</keyword>
  <keyword>Appetite Regulation</keyword>
  <keyword>Gastrointestinal microbiome</keyword>
  <keyword>Caloric Restriction</keyword>
  <keyword>Body weight maintenance</keyword>
  <keyword>Body composition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

